Daignan-Fornier Bertrand, Pinson Benoît
Université Bordeaux, CNRS, IBGC, UMR 5095, F-33000 Bordeaux, France.
Metabolites. 2012 Mar 23;2(2):292-302. doi: 10.3390/metabo2020292.
AICAR (5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-monophosphate) is a natural metabolic intermediate of purine biosynthesis that is present in all organisms. In yeast, AICAR plays important regulatory roles under physiological conditions, notably through its direct interactions with transcription factors. In humans, AICAR accumulates in several metabolic diseases, but its contribution to the symptoms has not yet been elucidated. Further, AICAR has highly promising properties which have been recently revealed. Indeed, it enhances endurance of sedentary mice. In addition, it has antiproliferative effects notably by specifically inducing apoptosis of aneuploid cells. Some of the effects of AICAR are due to its ability to stimulate the AMP-activated protein kinase but some others are not. It is consequently clear that AICAR affects multiple targets although only few of them have been identified so far. This review proposes an overview of the field and suggests future directions.
AICAR(5-氨基咪唑-4-甲酰胺-1-β-D-呋喃核糖基5'-单磷酸)是嘌呤生物合成的天然代谢中间体,存在于所有生物体中。在酵母中,AICAR在生理条件下起重要的调节作用,特别是通过其与转录因子的直接相互作用。在人类中,AICAR在几种代谢疾病中积累,但其对症状的作用尚未阐明。此外,AICAR最近显示出极具前景的特性。事实上,它能增强久坐小鼠的耐力。此外,它具有抗增殖作用,特别是通过特异性诱导非整倍体细胞凋亡。AICAR的一些作用归因于其刺激AMP活化蛋白激酶的能力,但其他一些作用并非如此。因此,很明显AICAR影响多个靶点,尽管到目前为止仅鉴定出少数靶点。本综述对该领域进行了概述并提出了未来的方向。